SavedAdd your journal

Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2013 / Cilt: 10 - Sayı: 3

ONCOFERTILITY: FERTILITY PRESERVATION IN CANCER PATIENTS

ONKOFERTİLİTE: KANSER HASTALARINDA FERTİLİTE PREZERVASYONU

Aslı NEHİR
Ercan BAŞTU
Bülent BAYSAL
Pages
173–180
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is to present the latest advances in oncofertility.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gynecologic cancers are among the most common type of cancer in women.
📊
Key Findings & Data:Previously, cancer treatment focused on eradicating the disease without paying particular attention to the patient's age or her future fertility plans.
💡
Conclusion & Impact:The purpose of this review is to present the latest advances in oncofertility.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gynecologic cancers are among the most common type of cancer in women. Previously, cancer treatment focused on eradicating the disease without paying particular attention to the patient's age or her future fertility plans. Advances in the field of oncology especially in early detection and treatment management, improved the prognosis of cancer patients. Therefore, in recent years quality of life after treatment became an important consideration for cancer patients. Today, fertility preservation (FP) plays a vital role in the management of gynecologic cancers. At the crossroads between gynecologic oncology and infertility lies a new field of medicine, namely oncofertility. The purpose of this review is to present the latest advances in oncofertility.

Özet

Kadınları etkileyen kanserler arasında jinekolojik olanlar büyük yer tutmaktadır. Geçmişte, kanser tedavileri hastanın yaşına ve ilerdeki fertilite planlarına bakılmaksızın, kanser hastalığını yok etmeyi hedeşemekteydi. Onkolojideki erken tanı ve tedavi yöntemlerindeki gelişmeler, jinekolojik kanser hastalarının prognozunu iyileştirmiştir. Bu sebeple, son yıllarda bu hastaların tedavi sonrası hayat kalitesi kayda değer bir unsur haline gelmiştir. Günümüzde fertilite prezervasyonu (FP), jinekolojik kanser yönetiminde önemli bir yere sahiptir. Onkoloji ve infertilite bilim dallarının kesiştiği noktada doğan 'onkofertilite' dalındaki son gelişmeleri sunmak bu derlemenin temel amacıdır.

🔖

Cite This Article

NEHİR, A., BAŞTU, E., BAYSAL, B. (2022). ONCOFERTILITY: FERTILITY PRESERVATION IN CANCER PATIENTS. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 10 - Sayı: 3, 173–180. https://ajindex.com/articles/631526

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. SEER Cancer Statistics. (http://seer.cancer.gov); February 3 2010
  2. Carter J, Sonoda Y, Abu-Rustum N. Reproductive concerns of women treated with radical trachelectomy for cervical cancer. Gynecol Oncol 2007; 105: 13- 6
  3. Eskander RN, Randall LM, Berman ML, Tewari KS, Disaia PJ, Bristow RE. Fertility preserving options in patients with gynecologic malignancies. Am J Obstet Gynecol. 2011; 205(2): 103- 10
  4. Morris SN, Ryley D. Fertility preservation: nonsurgical and surgical options. Semin Reprod Med. 2011; 29(2): 147- 54
  5. Goodwin P, Ennis M, Pritchard K, Trudeau M, Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999; 17: 2365- 9
  6. Knopman JM, Papadopoulos E, Grifo J, Fino ME, Noyes N. Surviving childhood and reproductive age malignancy: effects of treatment on fertility, gametes and future parenthood. Lancet Oncol 2010; 11: 490- 8
  7. Elkayam U, Tummala P, Rao K, Akhter M, Karaalp I, Wani O, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomy- opathies. N Engl J Med 2001; 344: 1567- 71
  8. Fischer MJ, Lehnerz SD, Hebert JR, Parikh CR. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis 2004; 43: 415- 23
  9. Fossa S, Magelssen H, Melve K, Jacobsen A, Langmark F, Skjoerven R. Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report. J Natl Cancer Inst Monogr 2005; 34: 77- 82
  10. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer 1989; 43: 399- 402
  11. Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus-review of the effects of treatment of childhood cancer. Hum Fertil (Camb) 2002; 5: 61- 6
  12. Hancock S, Tucker M, Hoppe R. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270: 1949- 55
  13. Aleman B, van den Belt-Dusebout A, De Bruin M, van 't Veer M, Baaijens M, de Boer J, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007; 109: 1878- 86
  14. Schover LR. Rates of postcancer parenthood. J Clin Oncol 2009; 27: 321- 2
  15. Byrne J, Rasmussen S, Steinhorn S, Connelly R, Myers M, Lynch CF, et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 1998; 62: 45- 52
  16. Li F, Fine W, Jaffe N, Holmes G, Holmes F. Offspring of patients